IE
ACHV icon

Israel Englander’s Achieve Life Sciences ACHV Stock Holding History

Israel Englander’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,077,338
Closed -$3.17M – 5800
2026
Q1 		$3.17M Sell
1,077,338
-281,778
-21% -$1.25M ﹤0.01% 3423
2025
Q4 		$6.75M Buy
1,359,116
+1,121,614
+472% +$4.89M ﹤0.01% 2683
2025
Q3 		$748K Sell
237,502
-148,698
-39% -$408K ﹤0.01% 4833
2025
Q2 		$873K Buy
386,200
+364,098
+1,647% +$1.04M ﹤0.01% 4511
2025
Q1 		$59K Buy
+22,102
New +$68.7K ﹤0.01% 5520
2024
Q3 		– Sell
-18,295
Closed -$86K – 6037
2024
Q2 		$86K Sell
18,295
-175,343
-91% -$845K ﹤0.01% 5335
2024
Q1 		$880K Buy
+193,638
New +$860K ﹤0.01% 4411
2023
Q4 		– Sell
-23,605
Closed -$102K – 6016
2023
Q3 		$102K Buy
+23,605
New +$119K ﹤0.01% 5333
2023
Q1 		– Sell
-30,422
Closed -$75K – 6293
2022
Q4 		$75K Buy
+30,422
New +$78.1K ﹤0.01% 5662
2021
Q3 		– Sell
-101,986
Closed -$916K – 6715
2021
Q2 		$916K Buy
+101,986
New +$971K ﹤0.01% 4744
2021
Q1 		– Sell
-19,971
Closed -$162K – 5837
2020
Q4 		$162K Buy
+19,971
New +$169K ﹤0.01% 4915
2020
Q2 		– Sell
-2,620
Closed -$17K – 4119
2020
Q1 		$17K Buy
+2,620
New +$25.3K ﹤0.01% 3742
2016
Q1 		– Sell
-16
Closed -$43K – 3216
2015
Q4 		$43K Sell
16
-34
-68% -$144K ﹤0.01% 3318
2015
Q3 		$245K Buy
50
+34
+213% +$205K ﹤0.01% 3017
2015
Q2 		$81K Buy
+16
New +$79.4K ﹤0.01% 3195
2015
Q1 		– Sell
-10
Closed -$50K – 3516
2014
Q4 		$50K Sell
10
-6
-38% -$29.3K ﹤0.01% 3831
2014
Q3 		$93K Sell
16
-149
-90% -$1.03M ﹤0.01% 3562
2014
Q2 		$1.36M Buy
165
+129
+358% +$1.58M ﹤0.01% 2013
2014
Q1 		$929K Buy
36
+28
+350% +$688K ﹤0.01% 2275
2013
Q4 		$143K Buy
+8
New +$140K ﹤0.01% 3302

Other funds holding ACHV

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Israel Englander's ACHV Position: Q2 2026 in Review

Israel Englander sold out of Achieve Life Sciences (ACHV) in Q2 2026, closing a stake of 1,077,338 shares — an estimated $3.17M sold.

Israel Englander first reported a position in ACHV in Q4 2013 and held it in 20 quarters. The position peaked at $6.75M in Q4 2025. 110 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • Israel Englander reported no remaining Achieve Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 1,077,338 Achieve Life Sciences shares in Q2 2026, an estimated $3.17M.
  • Israel Englander first reported a position in Achieve Life Sciences in Q4 2013 and held it in 20 quarters.
  • Israel Englander's Achieve Life Sciences position peaked at $6.75M in Q4 2025.
  • 110 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.